Data as of Q4 2025 (Dec 31, 2025)

SPHERA FUNDS MANAGEMENT LTD.

โ€ขCIK: 1496201โ€ขFiling: Q4 2025

SPHERA FUNDS MANAGEMENT LTD. oversees $509M in assets, with a concentrated portfolio of 98 positions. The fund's top holdings include TEVA, comprising 6.9% of the portfolio at $35.1M, and BIIB, representing 3.3% at $16.7M. Notable allocations also include MLYS, SNDX, and ASBA, totaling $48M, or 9.4% of the portfolio. The fund's largest sector exposure is to pharmaceuticals, with AZN, BKFDF, COGT, PRAX, and SNY collectively accounting for $64.1M, or 12.6% of assets under management.

Total AUM
$478.5M
+ $30.7M in options
QoQ Performance
+15.2%
Positions
93
+ 4 options
Top 10 Concentration
32.1%
Latest Filing
Q4 2025

Top Holdings Allocation

TEVA
TEVA6.9%
BIIB3.3%
MLYS3.2%
SNDX3.1%
NVMI3.1%
TSEM2.8%
COGT2.6%
AZN2.4%

๐Ÿ“ˆ Biggest Buys

COGT
COGENT BIOSCIENCES INC
+284.2%
2.6% of portfolio
BMRN
BIOMARIN PHARMACEUTICAL INC
NEW
1.7% of portfolio
XBIPUT
SPDR SERIES TRUST
NEW
1.7% of portfolio
MLYS
MINERALYS THERAPEUTICS INC
+104.2%
3.2% of portfolio
SNDX
SYNDAX PHARMACEUTICALS INC
+96.7%
3.1% of portfolio

๐Ÿ“‰ Biggest Sells

TSEM
TOWER SEMICONDUCTOR LTD
-60.7%
2.8% of portfolio
TEVA
TEVA PHARMACEUTICAL INDS LTD
-25.4%
6.9% of portfolio
NSYCALL
NICE LTD
-64.6%
1.2% of portfolio
FBRX
FORTE BIOSCIENCES INC
-60.8%
1.0% of portfolio
PRAXCALL
PRAXIS PRECISION MEDICINES I
-30.9%
2.3% of portfolio

Sector Breakdown

Other92.0%
Healthcare6.6%
Technology1.4%

๐Ÿšช Exited Positionssold since Q3 2025

2GH
MERUS N V
SOLD
$14.1M
NDQ
INVESCO QQQ TR
SOLD
$13.8M
CDTX
CIDARA THERAPEUTICS INC
SOLD
$7.3M
CLBT
CELLEBRITE DI LTD
SOLD
$5.5M
RAPP
RAPPORT THERAPEUTICS INC
SOLD
$4.7M
+26 more exited positions

Changes from Q3 2025

NEW24 new positions
โ†‘32 increased
โ†“27 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023